[WEBINAR] How to develop scale-up strategies for challenging crystallization processes
[WEBINAR] Scale-up of crystallization processes is rarely trivial & often necessitates careful consideration and in-depth understanding of process parameters.
Cutting edge process development insights and news from APC.
[WEBINAR] Scale-up of crystallization processes is rarely trivial & often necessitates careful consideration and in-depth understanding of process parameters.
Our expert, Dr. Jacek Zeglinski talks about the various challenges which drug substance developers face when seeking to develop material suitable for tabletting
Particle sizing is hugely important. However, it is laden with complexities and there is a general misunderstanding of the techniques used.
[WEBINAR] Industry bottlenecks in drug substance development: solubility, particle size, and morphology. Meta title text: Crystallization Bottlenecks in Drug Substance Development
Subtle changes in particle size, shape, & distribution can have a major impact on pharma solubility and stability and cause flow and formulation issues.
[WEBINAR] Good crystallization process design, can save months of development time. But, crystallization of stereoisomers can be particularly challenging.
[WEBINAR] Traditional solvent screening takes too long to fix issues for fast-moving clinical candidates. But modeling & smart experiments speed things up.